Differences in
to the same blood level of lead. Thus lead poisoning of infants is still a serious public health problem despite many years of intensive investigation. The reasons why lead affects infants more severely than adults are believed to be as follows: the rapid absorption of lead from the intestinal tract, the greater degree of lead retention, and the rapid growth of infants1,2). One of the most obvious sites of the toxic action of lead is the heme biosynthetic pathway, especially the inhibition of erythrocyte 6-aminolevulinic acid dehydratase (ALA-D; 5-aminolevulinate hydro-lyase, EC 4.2.1.24), which is widely noted as a sensitive indicator1-4). Recently, a radioimmunoassay (RIA) for rat ALA-D was developed, and its use for adult rats given lead revealed that the amount of ALA-D increased to twice that in the controls in contrast with its decreased activity5). It was also shown that the increase in the amount of ALA-D in bone marrow cells preceded that in peripheral erythrocytes by more than 5 days5).
Under the conditions employed, no sign of anemia with increased numbers of reticulocytes was observed in either lead-treated or untreated groups. The increase in the amount of ALA-D in erythrocytes was therefore considered to be due to increased synthesis of the enzyme in bone marrow cells to compensate for the inhibition5). A RIA for human ALA-D was also developed, and its application to lead-exposed workers made it evident that the increase in the amount of ALA-D without anemia was one of the most sensitive parameters of lead exposure6). In addition, an increase in enzyme content coupled with decrease in its activity was observed in lead-exposed human subjects6) as in the case of rats5). Although these reports indicate the importance of the amount of ALA-D in lead exposure, the amount in lead-poisoned infants was not studied and no comparison was made between lead-exposed infants and adults. In the present study, therefore, 3-and 16-week-old rats of the same (Wistar) strain were, given drinking water containing 25 mM lead acetate, under the same conditions, in order to compare the effect of lead on infants with that on adults. The ALA-D content was determined by RIA.
Maes and Gerber7) reported phenomenally increased activity of ALA-D as determined by the European Standardized Method in infant rats given a diet containing lead acetate at 1% . In our study, the significance of the activity revealed by the European Standardized Method was examined and the results of the present study was compared with those reported by Mas and Gerber7). 
Enzyme assays
The activity of ALA-D without dithiothreitol (DTT) and zinc treatment was routinely determined by the modified European Standardized Method5) (the modified method), in which the lead-chelating phosphate buffer was replaced with Tris-acetate buffer, and will be called the non-restored activity. When necessary, the activity of ALA-D determined by the European Standardized Method8) and the activity after treatment with DTT and zinc5,9) were also determined. The activity after zinc and DTT treatment will be referred to as the restored activity. The determination of the enzyme activity was carried out within 1 hour after blood sampling.
One unit of enzyme activity was defined as the activity which catalyzes the formation of 1 t.tmole of porphobilinogen formed per hour at 37°C. The protein concentration was determined by the method of Lowry et al.1°) The absorption spectra were recorded with a Hitachi model 200-10 spectrophotometer. 3 . Radioimmunoassay (4) Radioimmunoassay procedure: The RIA for rat ALA-D was performed by the method of Fujita et al.5), and the results will be referred to as the RIAbased amount.
Determination of lead
For the determination of the lead in blood, the samples were digested with HNO3 and analyzed with a flameless atomic absorption spectrophotometer (Nippon Jarrell Ash AA-8200, FLA-100).
All glassware was washed with HNO3/HCl and rinsed thoroughly with metal-free distilled water. K. SATO AND M. IKEDA 5. Administration of lead to rats Male Wistar rats, 3 and 16 weeks old, were housed individually in stainless steel wire cages and kept in a temperature-controlled and light-regulated animal room. The 3-week-old rats were divided into a control group (6 rats with a mean body weight of 55.3 g) and a lead-treated group (6 rats with a mean body weight of 54.8 g). The animals in the latter group were given 25 mM lead acetate in deionized water ad libitum. Body weight, hematocrit, reticulocyte counts and typing, erythrocyte ALA-D activity and its RIA-based amount, and the blood lead content were determined 3 and 4 weeks after the initiation of lead administraiton. The 16-week-old rats were also divided into a control group (4 rats with a mean body weight of 308 g) and a lead-treated group (4 rats with a mean body weight of 314 g), and the test group were also given 25 mM lead acetate-containing water ad libitum. After 4 weeks of lead treatment, hematological examinations and body weight measurements were carried out. 
Comparison of the hematological effect of lead in adult and infant rats
The results of administration of lead to rats are summarized in Tables 1 and 2 .
Blood lead levels of infant rats after 3 or 4 weeks of lead treatment were almost equal to those of the adult rats after 4 weeks of lead administration.
After lead administration, non-restored activity of ALA-D in infant rats de- • 
